Note: Ingredients listed on restricted chemical lists
EC/CAS
7647-01-0
Name of the chemical
Hydrochloric acid
Concentration
N/A
EC/CAS
1310-73-2
Name of the chemical
sodium hydroxide
Concentration
N/A
General Information
Revision date
2021-11-19
Product name
Tigecycline for Injection
Chemical name
Tigecycline for Injection
REACH No
medicinal
1.2.1 Relevant identified uses
Pharmaceutical product
Emergency telephone
800 424 9300
Icons in SDS
Company Information
company name
Xellia Pharmaceuticals ApS
e-mail address of the competent person responsible for the Safety Data Sheet
sales@xellia.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H361, H401
Hazard statements
Code
Statements
H361
Suspected of damaging fertility or the unborn child
Section 2
SECTION 2: Hazards identification
EMERGENCY OVERVIEW This is a medicinal product that may affect body functions. When inside vials the hazard is considered negligible.
2.1 Classification of the substance or mixture
CLP:
Hazard statements
H361 Suspected of damaging fertility or the unborn child. H401 Toxic to aquatic life
Precautionary statements
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P273 Avoid release to the environment. P281 Use personal protective equipment as required. P308+P313 If exposed or concerned Get medical advice/attention. P405 Store locked up. P501 Dispose of contents/container in accordance with local/regional/ national/ international regulations.
Contains
Tigecycline for Injection WARNING
2.3 Other hazards
None known. PBT/vPvB: The substance is not considered PBT/vPvB according to criteria in Annex XIII.
